Main Menu

Sunday, December 17th, 2017

 

Cannabis ingredient holds promise as antipsychotic medicine

Cannabis ingredient holds promise as antipsychotic medicine Kate Kelland | December 15, 2017 Scientists conducted a small trial of people with psychosis and found patients treated with CBD had lower levels of psychotic symptoms than those who received a placebo. Psychosis is characterized by paranoia and hallucinations. The study found that they were also more likely to be rated as “improved” by their psychiatrist and there were signs of better cognitive performance and functioning. Cannabis ingredient holds promise as antipsychotic medicine


Marijuana retail chain operator Sweet Leaf forced to shut down in Denver area

Marijuana retail chain operator Sweet Leaf forced to shut down in Denver area December 14, 2017 | Bart Schaneman Sweet Leaf, one of Colorado’s largest marijuana retail chain operators, had all of its Denver-area stores shuttered Thursday as part of police raids that resulted in 12 arrests. Twenty-six of the vertically integrated company’s licenses have been suspended, according to Dan Rowland, spokesman for the Denver Department of Excise and Licensing. The Denver Police Department and other agencies executed search and arrest warrants on eight marijuana retail stores across the metroRead More


Medical marijuana has no health risks: WHO

Medical marijuana has no health risks: WHO Brittany Vonow, The Sun | December 13, 2017 The World Health Organization (WHO) has officially given the checkmark of approval to cannabidiol, a relaxing compound in medical marijuana, ruling it is not a dangerous drug. The compound, also known as CBD, can be an effective treatment for cancer, Alzheimer’s, epilepsy and in palliative care, with WHO now ruling it does not have any risks of addiction. The ruling means that it should not be a scheduled drug – meaning that it is notRead More


Opioid Crisis: Trump Prescribes Heavy Dose of ‘Alternative Facts’

Opioid Crisis: Trump Prescribes Heavy Dose of ‘Alternative Facts’ David Bienenstock | December 11, 2017 Back in August, the president of the United States traveled to Huntington, West Virginia—a town of 48,000 where the mayor estimates one in 10 residents is addicted to opioids. “You have a big problem,” the president told an adoring public rally, “and we are going to solve that problem.” He didn’t explain how he would solve the problem. That’s not Trump’s style (“Believe me, believe me, believe me”). But four months later, the plan isRead More


iCan Israel-Cannabis To Bring FDA Approved Nebulizers To Medical Cannabis Market

iCan Israel-Cannabis To Bring FDA Approved Nebulizers To Medical Cannabis Market December 12, 2017 | MJ News Network iCAN Israel-Cannabis and Aura Medical have joined forces to bring FDA approved nebulizers to the burgeoning medical cannabis market. The Aura’s Portable Nebulizer is widely acclaimed and recommended by the nation’s top Pulmonologists and Respiratory Therapists for use in treating asthma and COPD and now will be used by millions more worldwide. The device will be marketed under the brand name “Nebican.” iCan Israel-Cannabis To Bring FDA Approved Nebulizers To Medical CannabisRead More